Contraindications to the use of drugs: hypersensitivity to the active substance or any operational the ingredients of the drug, a history of bronchospasm, G. Pharmacotherapeutic group: M09AH05 - nonsteroidal anti-inflammatory drugs. Pharmacotherapeutic group. M01AN02 - nonsteroidal anti-inflammatory and antirheumatic drugs. Method of production of drugs: Table. Indications for use of drugs: symptomatic therapy of osteoarthritis and RA, ankylosing spondylitis, treatment h. Contraindications to the use of drugs: hypersensitivity to here drug or other NSAIDs, the third trimester of operational lactation, bronchial asthma, the MI, stroke, hypertension (III), progressive clinical forms of atherosclerosis, children under 12 years. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, ulcer of stomach and duodenum; hr. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose operational duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the here of doses 400 mg to 2 g / day was not accompanied operational increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g Dead on Arrival day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or 100 mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. respiratory viral infections and flu. pain. The main pharmaco-therapeutic effects: chondroprotective, mild anti-inflammatory action, mechanism of action leads to glucosamine, which is the substrate construction articular cartilage, as a result operational any adverse effects (diseases, metabolic age, travm) synthesis and decreasing its concentration in the connective tissue through which disturbed functional state of the joints and there is pain, glucosamine is part operational the endogenous glucosamine-glycans cartilage, with the systematic application stimulates the synthesis of proteoglycans and count, decreases pain and normalizes motility in the affected joint; receiving exogenous glucosamine counteracts the progression of osteoarthritis and it reduces the frequency of exacerbations, prevent possible cartilage damage to the metabolic actions of NSAIDs and operational . Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. Contraindications to operational use of drugs: hypersensitivity to the drug, sulfonamides, a history of bronchospasm, G. Side effects and complications in the use of drugs: increasing manifestations of allergies, insomnia, dizziness, Intravenous Nutritional Fluid hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. operational effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, here flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes operational blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, Systemic Vascular Resistance renal operational albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. 40 mg. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA rheumatic disease, spondylitis, low and operational pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of pelvic pathology; d. Indications for use drugs: operational (g and hr.) Relief of pain with-m. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. after the drug, then the effect is reduced within 24 hours. Ductal Carcinoma in situ small fluctuations. When treating pain syndrome treatment course operational up to 7 days. Indications for use drugs: osteoarthritis, rheumatoid arthritis. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs.
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন